Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients

SIMPLE SUMMARY: Gastroesophageal adenocarcinoma (GEA) has a poor prognosis. However, since the HER2 positive subgroup could benefit from trastuzumab targeted therapy, considerable effort has been spent in determining the HER2 status in these patients. To date, immunohistochemistry and in situ hybrid...

Descripción completa

Detalles Bibliográficos
Autores principales: Boldrin, Elisa, Mazza, Marcodomenico, Piano, Maria Assunta, Alfieri, Rita, Montagner, Isabella Monia, Magni, Giovanna, Scaini, Maria Chiara, Vassallo, Loretta, Rosato, Antonio, Pilati, Pierluigi, Scapinello, Antonio, Curtarello, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102116/
https://www.ncbi.nlm.nih.gov/pubmed/35565309
http://dx.doi.org/10.3390/cancers14092180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102116/
https://www.ncbi.nlm.nih.gov/pubmed/35565309
http://dx.doi.org/10.3390/cancers14092180

Ejemplares similares